BAL PHARMA LTD. (BALPHARMA)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 82.45 70.39 92.54 81.66 94.63 74.36 73.69 73.15 81.88 65.87 74.02 87.69
YOY Revenue Growth % 19.21% -4.95% 32.51% 6.58% 14.77% 5.64% -20.37% -10.42% -13.47% -11.41% 0.45% 19.87%
Other Income 0.19 0.16 0.14 0.10 2.45 0.82 -0.20 0.51 1.08 0.72 1.12 0.33
Total Income 82.64 70.54 92.68 81.76 97.08 75.18 73.49 73.66 82.96 66.59 75.14 88.02
Total Expenses + 79.86 66.66 81.75 65.93 83.17 65.12 65.30 66.12 80.37 66.38 74.42 86.23
Cost of Materials Consumed 50.67 41.55 50.22 37.91 51.90 36.31 37.29 37.58 38.70 36.03 40.29 43.51
Employee Benefit Expense 14.63 14.19 15.30 15.26 15.64 14.91 16.02 15.98 15.49 14.80 16.27 17.32
Other Expenses 14.56 10.93 16.23 12.76 15.63 13.91 11.98 12.57 14.77 11.46 12.09 14.66
Operating Profit 2.59 3.72 10.79 15.73 11.46 9.23 8.39 7.03 1.51 -0.51 -0.40 1.46
OPM % 3.1% 5.3% 11.7% 19.3% 12.1% 12.4% 11.4% 9.6% 1.8% -0.8% -0.5% 1.7%
Profit Before Tax + 2.41 0.43 1.60 1.27 5.75 0.62 1.36 0.57 2.59 0.21 0.72 1.79
Tax Expense 0.79 0.34 0.63 0.42 0.22 0.36 0.32 0.05 -2.78 0.00 0.00 0.00
Tax % 32.9% 78% 39.4% 32.9% 3.8% 58% 23.5% 8.5% -107.3% 0% 0% 0%
Profit After Tax 1.62 0.09 0.97 0.85 5.53 0.26 1.04 0.52 5.38 0.21 0.72 1.79
EPS (Basic) 1.03 0.06 0.62 0.54 3.73 0.16 0.65 0.33 3.40 0.13 0.45 1.12

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
Revenue from Operations 303.08 339.22 304.22 281.21 250.53 171.09 211.75
YOY Revenue Growth % -10.65% 11.51% 8.18% 12.25% 46.43% -19.2% -
Other Income 2.20 2.85 0.94 5.15 1.14 1.84 1.57
Total Income 305.29 342.07 305.16 286.37 251.67 172.93 213.33
Total Expenses + 300.15 297.52 285.52 254.21 210.59 154.41 198.00
Cost of Materials Consumed 149.89 181.58 179.19 163.99 135.47 72.20 102.96
Employee Benefit Expense 62.40 60.38 55.30 47.25 41.88 50.43 47.18
Other Expenses 53.23 55.56 51.03 42.96 33.25 31.78 47.86
Operating Profit 2.93 41.70 18.70 27.01 39.94 16.69 13.76
OPM % 1% 12.3% 6.1% 9.6% 15.9% 9.8% 6.5%
Profit Before Exceptional 5.14 9.05 4.75 9.18 4.10 -13.53 2.88
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 5.14 9.05 4.75 9.18 4.10 -13.53 2.88
Tax Expense -2.06 1.60 2.13 3.48 -0.61 -0.64 2.51
Tax % -40.2% 17.7% 44.8% 37.9% -14.9% - 86.9%
Profit After Tax 7.20 7.45 2.62 5.70 4.71 -12.89 0.38
EPS (Basic) 4.56 4.94 1.67 3.79 3.34 -8.62 0.20

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
ASSETS
Non-Current Assets + 100.82 85.38 85.02 0.00 0.00 0.00 0.00
Property, Plant & Equipment 70.99 61.61 62.18 0.00 0.00 0.00 0.00
Capital Work in Progress 2.79 0.47 0.00 0.00 0.00 0.00 0.00
Non-Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 3.83 3.83 3.83 0.00 0.00 0.00 0.00
Other Intangible Assets 12.00 11.38 10.46 0.00 0.00 0.00 0.00
Current Assets + 234.87 235.01 228.16 0.00 0.00 0.00 0.00
Inventories 103.02 87.81 98.01 0.00 0.00 0.00 0.00
Trade Receivables 92.44 99.62 93.98 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 1.75 4.20 1.49 0.00 0.00 0.00 0.00
Current Investments 2.47 6.76 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 15.92 15.80 15.69 0.00 0.00 0.00 0.00
Other Equity 61.50 53.49 48.10 0.00 0.00 0.00 0.00
Non-Current Liabilities 38.79 47.22 40.14 0.00 0.00 0.00 0.00
Current Liabilities 219.50 203.91 209.33 0.00 0.00 0.00 0.00
Total Liabilities 258.29 251.13 249.47 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
Cash from Operating Activities 20.74 329.19 23.02 32.05 0.00 0.00 0.00
Cash from Investing Activities -18.13 0.00 18.43 11.34 0.00 0.00 0.00
Cash from Financing Activities 0.29 34.58 0.00 1.11 0.00 0.00 0.00
Net Increase/Decrease in Cash 2.90 363.78 41.45 44.50 0.00 0.00 0.00